Lloyd B Klickstein

USPTO Granted Patents = 13 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 234(Granted Patents)

Location History:

Brookline, MA (US) (1993 - 2001)
Newton, MA (US) (2016 - 2022)

Company Filing History:

5 out of 3,685

Johns Hopkins University

patents

5 out of 1,371

The Brigham and Women's Hospital, Inc.

patents

4 out of 24

T Cell Sciences, Inc.

Mereo Biopharma 2 Limited

patents

6. 2 out of 20

Avant Immunotherapeutics, Inc.

patents

7. 1 out of 1

Merco Biopharma 2 Limited

patent

where one patent can have more than one assignee

Years Active: 1993-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11357851 - Uses of myostatin antagonists, combinations containing them and uses thereof (2022-06-14),

2. 11179364 - Licofligozin for the treatment of non-alcoholic steatohepatitis (2021-11-23),

3. 10064844 - Pharmaceutical compositions comprising an aromatse inhibitors (2018-09-04),

4. 9750724 - Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases (2017-09-05),

5. 9370505 - Pharmaceutical compositions comprising an aromatse inhibitors (2016-06-21),

6. 9296826 - Antibodies and methods for WNT pathway-related diseases (2016-03-29),

7. 9295668 - Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases (2016-03-29),

8. 6316604 - Human C3b/C4b receptor (CR1) (2001-11-13),

9. 5981481 - Human C3b/C4b receptor (CR1) (1999-11-09),

10. 5856297 - Human C3b/C4b receptor (CR1) (1999-01-05),

11. 5472939 - Method of treating complement mediated disorders (1995-12-05),

12. 5256642 - Compositions of soluble complement receptor 1 (CR1) and a thrombolytic (1993-10-26),

13. 5212071 - Nucleic acids encoding a human C3b/C4b receptor (CR1) (1993-05-18),

Title: The Innovative Journey of Lloyd B Klickstein

Introduction:

Lloyd B Klickstein, a prominent inventor based in Newton, MA (US), has made significant contributions to the field of healthcare with his groundbreaking patents and research endeavors. With a portfolio of 7 patents to his name, Klickstein's work has focused on developing novel treatments for conditions such as cancer cachexia and non-alcoholic steatohepatitis.

Latest Patents:

Klickstein's recent patents include "Uses of myostatin antagonists, combinations containing them and uses thereof," which highlights the efficacy of myostatin antagonist bimagrumab in treating cancer cachexia. Additionally, his patent for Licofligozin addresses the treatment of non-alcoholic steatohepatitis, showcasing his dedication to finding innovative solutions for complex medical conditions.

Career Highlights:

Having worked with esteemed companies like Novartis AG and Mereo Biopharma 2 Limited, Klickstein has demonstrated his expertise in the pharmaceutical industry. His inventive spirit and commitment to improving healthcare outcomes have been a driving force behind his successful career as an inventor and researcher.

Collaborations:

Throughout his career, Klickstein has collaborated with industry experts such as Ann Taylor and Jeewan Thakur. These collaborations have not only enriched his research initiatives but have also paved the way for new discoveries and advancements in the field of medicine.

Conclusion:

Lloyd B Klickstein's journey as an inventor exemplifies the power of innovation and perseverance in tackling complex healthcare challenges. His patents and collaborations stand as a testament to his dedication to improving the lives of individuals affected by debilitating conditions. Klickstein's work continues to inspire future generations of inventors and researchers in the pursuit of transformative healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.